These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32486612)

  • 1. microRNA-216a-5p inhibits the development of gastric cancer through target combination with TCTN1.
    Xu X; Gao F; Wang J; Long C; Tao L; Ding L; Ji Y
    Minerva Med; 2023 Jun; 114(3):323-331. PubMed ID: 32486612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-216a-5p targets TCTN1 to inhibit cell proliferation and induce apoptosis in esophageal squamous cell carcinoma.
    Chai L; Yang G
    Cell Mol Biol Lett; 2019; 24():46. PubMed ID: 31297133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
    Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
    Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-195-5p inhibits malignant progression of gallbladder cancer by regulating Wnt3a.
    Sun HD
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):7635-7642. PubMed ID: 34982425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
    Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10761-10768. PubMed ID: 31858543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-135 inhibits gastric cancer metastasis by targeting SMAD2.
    He Y; Wu L; Dai Y; Li J; Liu S
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9436-9444. PubMed ID: 31773690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
    Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-133a-5p inhibiting metastatic capacity of renal clear cell carcinoma through regulating MON2.
    Li P; Wu Q; Yang XR; Sun T
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5988-5995. PubMed ID: 32572912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of circ_0011946 targets miR-216a-5p/BCL2L2 axis to regulate proliferation, migration, invasion and apoptosis of oral squamous cell carcinoma cells.
    Zhou Y; Zhang S; Min Z; Yu Z; Zhang H; Jiao J
    BMC Cancer; 2021 Oct; 21(1):1085. PubMed ID: 34620126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiRNA-339-5p suppresses the malignant development of gastric cancer via targeting ALKBH1.
    Wang C; Huang Y; Zhang J; Fang Y
    Exp Mol Pathol; 2020 Aug; 115():104449. PubMed ID: 32380054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
    Yang XY; Li N; Deng WY; Ma YJ; Han XL; Zhang ZY; Xie JL; Luo SX
    Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):193-199. PubMed ID: 30917455
    [No Abstract]   [Full Text] [Related]  

  • 14. Lnc00908 promotes the development of ovarian cancer by regulating microRNA-495-5p.
    Jiang JN; Hong QY; Gao HJ; Lai BL; Lan JF; Yang Q
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1388-1396. PubMed ID: 30840259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
    Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
    He SZ; Wang Q
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncSNHG14 promotes ovarian cancer by targeting microRNA-125a-5p.
    Zhao YL; Huang YM
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3235-3242. PubMed ID: 31081075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-33a-5p Targets RAP2A to Mediate the Sensitivity of Gastric Cancer Cells to 5-FU.
    Ti G; Guo Z; Li L; Lv Y; Yang B; Wang J; Guo R; Chen Y; Meng D; Li F
    Dis Markers; 2022; 2022():9701047. PubMed ID: 36046374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
    Li Y; Zhou HC; Zhang Y; Huang H
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-424-5p inhibits the development of non-small cell LCa by binding to ITGB1.
    Xu ZL; Zhang M; Chen SX; Qiu M; Zhang Q; Gao LP; Li JDX
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8921-8930. PubMed ID: 31696479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.